COTC030: Evaluation of Inhaled recombinant-human IL-15 combined with Standard-of-Care in Dogs with Osteosarcoma

condition(s)

osteosarcoma

eligibility information

Enrollment Deadline

Enrollment ends August 22, 2022

contact information